Biochimica et Biophysica Acta: Molecular Basis of Disease
Volume 1 • Issue 8
- ISSN: 0925-4439
- 5 Year impact factor: 5.5
- Impact factor: 4.2
BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease.Manuscripts should emphas… Read more
Subscription options
Institutional subscription on ScienceDirect
Request a sales quoteBBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease.
Manuscripts should emphasize the underlying molecular mechanisms of human disease pathways and provide significant advances to the understanding and/or treatment of these disorders.
Studies in model organisms or systems are strongly recommended in order to validate mechanistic insights.
Topics of interest include, but are not limited to
Aging
Cancer
Cardiovascular diseases
Cell death–related diseases
Genetic diseases
Genetic and epigenetic regulation in diseases
Immunological diseases
Inflammatory diseases
Metabolic diseases
Mitochondrial diseases
Muscular diseases
Neurological diseases
The non-preferred topics for BBADIS include
Non-coding RNAs
Research on non-coding RNAs (microRNAs, lncRNAs, circRNAs, etc.) will be considered only if it provides significantly novel insights into disease mechanisms.
Single Cell Line Studies
Studies involving single cell lines will be considered only if they present significantly novel findings.
Computational (in Silico) Studies
Purely computational works (e.g., Mendelian randomization, molecular docking, molecular dynamics) will generally be declined unless they provide novel insights into disease mechanisms.
Disease Biomarkers
Research on disease biomarkers will be considered only if it relates to the explanation of disease mechanisms.
Descriptive or Correlative Studies
Descriptive or correlative studies (e.g., up/down regulation of gene products, -omics studies without follow-up experiments) will be declined unless they provide mechanistic insights.
Natural Products and Traditional Medicine
Work on natural products, extracts, and traditional medicine will be considered only if single biochemical components are characterized and tested.
Clinical Studies and Case Reports
Clinical studies or case reports without mechanistic insights are outside the scope of the journal.
Hypothesis Articles
Submissions based solely on hypotheses will not be considered.
Comparative Genomics Studies
Comparative genomics studies (e.g., GWAS) will only be considered if they provide specific insights into the structural and/or functional properties of individual genes.
Incremental Work
Research that offers incremental advancements without significant novelty or impact will generally be declined.
- ISSN: 0925-4439
- Volume 1
- Issue 8
- 5 Year impact factor: 5.5
- Impact factor: 4.2